Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Sapiens International
SPNS
$2.4B
| $1.6M | ﹤0.01% |
74,982
-5,243
| -7% | -$112K |
|
1977
Altice USA
ATUS
$1.12B
| $1.6M | ﹤0.01% |
466,800
-55,400
| -11% | -$189K |
|
1978
Steelcase
SCS
$1.93B
| $1.59M | ﹤0.01% |
189,300
-22,400
| -11% | -$189K |
|
|
CBAY
1979
DELISTED
Cymabay Therapeutics
CBAY
| $1.59M | ﹤0.01% |
+182,700
| New | +$1.59M |
|
|
EXK
1980
Endeavour Silver
EXK
$1.78B
| $1.59M | ﹤0.01% |
413,000
-47,100
| -10% | -$182K |
|
|
PFC
1981
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.59M | ﹤0.01% |
76,715
-9,100
| -11% | -$189K |
|
1982
Sprinklr
CXM
$1.88B
| $1.58M | ﹤0.01% |
122,200
-11,400
| -9% | -$148K |
|
1983
Opko Health
OPK
$1.11B
| $1.58M | ﹤0.01% |
1,083,955
-127,600
| -11% | -$186K |
|
1984
Koppers
KOP
$567M
| $1.58M | ﹤0.01% |
45,100
-5,300
| -11% | -$185K |
|
1985
Douglas Dynamics
PLOW
$752M
| $1.58M | ﹤0.01% |
49,400
-5,800
| -11% | -$185K |
|
1986
Varex Imaging
VREX
$469M
| $1.57M | ﹤0.01% |
86,540
-9,800
| -10% | -$178K |
|
1987
Navitas Semiconductor
NVTS
$1.31B
| $1.57M | ﹤0.01% |
215,200
+51,500
| +31% | +$376K |
|
|
FRG
1988
DELISTED
Franchise Group, Inc.
FRG
| $1.57M | ﹤0.01% |
57,700
-10,500
| -15% | -$286K |
|
1989
Peoples Bancorp
PEBO
$1.08B
| $1.57M | ﹤0.01% |
61,000
-7,300
| -11% | -$188K |
|
1990
Usana Health Sciences
USNA
$557M
| $1.57M | ﹤0.01% |
24,900
-2,900
| -10% | -$182K |
|
1991
Opendoor
OPEN
$6.68B
| $1.57M | ﹤0.01% |
889,700
-97,300
| -10% | -$171K |
|
1992
SiriusPoint
SPNT
$2.22B
| $1.57M | ﹤0.01% |
192,500
-23,100
| -11% | -$188K |
|
1993
Iovance Biotherapeutics
IOVA
$821M
| $1.56M | ﹤0.01% |
255,556
-30,200
| -11% | -$185K |
|
|
BRSP
1994
BrightSpire Capital
BRSP
$764M
| $1.56M | ﹤0.01% |
264,400
+31,300
| +13% | +$185K |
|
1995
Algoma Steel
ASTL
$477M
| $1.56M | ﹤0.01% |
192,307
+51,600
| +37% | +$418K |
|
|
HIBB
1996
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.55M | ﹤0.01% |
26,300
-3,400
| -11% | -$201K |
|
1997
Standard Motor Products
SMP
$889M
| $1.55M | ﹤0.01% |
41,900
-4,900
| -10% | -$181K |
|
1998
Simulations Plus
SLP
$303M
| $1.54M | ﹤0.01% |
35,100
-4,000
| -10% | -$176K |
|
1999
Quanex
NX
$661M
| $1.54M | ﹤0.01% |
71,500
-8,900
| -11% | -$192K |
|
2000
DocGo
DCGO
$150M
| $1.54M | ﹤0.01% |
177,600
-17,600
| -9% | -$152K |
|